Literature DB >> 5900224

Catabolism and elimination of cholesterol in germfree rats.

B S Wostmann, N L Wiech, E Kung.   

Abstract

Three-month old germfree and conventional male rats were maintained on a complete steam-sterilized, semisynthetic diet. After intravenous injection of cholesterol-26-(14)C the animals were housed in a plastic metabolism chamber for 72 hr. Expired CO(2) was collected throughout the period. The conventional rats released 50% more (14)C as (14)CO(2) than the germfree animals. The total amount of the label recovered as (14)CO(2) during the 72 hr period amounted to 30% and 19% respectively, of the original dose. In both conventional and germfree rats the release of (14)CO(2) accounted for approximately 75% of the (14)C recovered in forms other than the original cholesterol-26-(14)C; 15-20% was found incorporated in water-soluble and fat-soluble fractions other than 3Beta-OH sterol of liver and carcass while the remainder was excreted with feces and urine. After the 72 hr period the specific activities of the cholesterol in plasma and liver were lower in conventional than in germfree animals. The data express the accelerating effect of the intestinal microflora on systemic cholesterol catabolism. They demonstrate that the release of (14)CO(2) from cholesterol-26-(14)C in the intact rat is a suitable and convenient indicator of the oxidative catabolism of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5900224

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

Review 1.  Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.

Authors:  Shivani Ghaisas; Joshua Maher; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2015-11-26       Impact factor: 12.310

Review 2.  Role of the gut in modulating lipoprotein metabolism.

Authors:  Alan A Hennessy; R Paul Ross; Gerald F Fitzgerald; Noel Caplice; Catherine Stanton
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

Review 3.  Contributions of gnotobiology to nutrition science.

Authors:  H Haenel; J Schulze
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

4.  Lowering of serum cholesterol by intestinal bacteria in cholesterol-fed piglets.

Authors:  G E Mott; R W Moore; H E Redmond; R Reiser
Journal:  Lipids       Date:  1973-07       Impact factor: 1.880

5.  Effect of fat and microflora on hepatic, small intestinal and colonic HMG CoA reductase, cytochrome P450 and cytochrome B5.

Authors:  P Smith-Barbaro; D Hanson; B S Reddy
Journal:  Lipids       Date:  1981-03       Impact factor: 1.880

6.  Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4.

Authors:  Carolien Out; Jay V Patankar; Marcela Doktorova; Marije Boesjes; Trijnie Bos; Sanna de Boer; Rick Havinga; Henk Wolters; Renze Boverhof; Theo H van Dijk; Anna Smoczek; André Bleich; Vinay Sachdev; Dagmar Kratky; Folkert Kuipers; Henkjan J Verkade; Albert K Groen
Journal:  J Hepatol       Date:  2015-05-27       Impact factor: 25.083

7.  Prevention of High-Fat Diet-Induced Hypercholesterolemia by Lactobacillus reuteri Fn041 Through Promoting Cholesterol and Bile Salt Excretion and Intestinal Mucosal Barrier Functions.

Authors:  Mengyao Lu; Jin Sun; Yuning Zhao; Haowen Zhang; Xinyue Li; Jingbo Zhou; Hongyang Dang; Jidong Zhang; Wenjing Huang; Ce Qi; Duo Li
Journal:  Front Nutr       Date:  2022-03-11

Review 8.  The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5.

Authors:  Annemarie Baars; Annemarie Oosting; Jan Knol; Johan Garssen; Jeroen van Bergenhenegouwen
Journal:  Microorganisms       Date:  2015-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.